Market News:
Market Watch by Dow Jones
eSignal System Status
Econoday US Week at a Glance
MSN Money
Briefing.com Economic Calendar
Shirmeyer Report: Economic Calendar
MarketWatch
Forbes Latest AP News
Earnings.com
News Feed below is updated at 4 minutes after every hour.
Hit F5 to refresh Internet Explorer.
Sovereign Soars on Speculation
Bank won't comment on talk of aid from Santander; investors seem to think it's true.
Look For Freddie To Follow Fannie
One lender sells common and preferred after Q1 loss; expect the same from the other.
Citi Aims To Trim Fat
Bank plans up to $500B of asset sales to concentrate on profitable businesses but will remain a universal bank.
Sanofi/Bristol-Myers Battle For Patent
Shares in Sanofi-Aventis fall after a new threat to its blood-thinning blockbuster drug.
Sponsor's Content: The Bottom Line on Sustainability
Research indicates a clear connection between a company's sustainability practices and the price of its shares. What's not so apparent is whether it's just a feel-good idea or actually good for cash flow.
Mylan Hopes To Patch Tear In Sheath
The generic drug manufacturer lowered guidance on bad earnings and pledged to sell its specialty drugmaker.
Investors Don't Want To Make Emeritus Home
Investors sold off the stock due to a lack of transparency with earnings.
Scrap Heap For Steel Dynamics
Industry consolidation persists with takeover of Recycle South.
Blockbuster, Icahn Open Up Circuit City
The troubled electronics maker is opening its books to suitors.
Investors Punish AIG
AIG tumbles after posting $7.8B in losses and making $9.1B in writedowns.
Mylan Expelling Injectables
The generic drug manufacturer lowered guidance on bad earnings and pledged to sell its specialty drugmaker.
Bank won't comment on talk of aid from Santander; investors seem to think it's true.
Look For Freddie To Follow Fannie
One lender sells common and preferred after Q1 loss; expect the same from the other.
Citi Aims To Trim Fat
Bank plans up to $500B of asset sales to concentrate on profitable businesses but will remain a universal bank.
Sanofi/Bristol-Myers Battle For Patent
Shares in Sanofi-Aventis fall after a new threat to its blood-thinning blockbuster drug.
Sponsor's Content: The Bottom Line on Sustainability
Research indicates a clear connection between a company's sustainability practices and the price of its shares. What's not so apparent is whether it's just a feel-good idea or actually good for cash flow.
Mylan Hopes To Patch Tear In Sheath
The generic drug manufacturer lowered guidance on bad earnings and pledged to sell its specialty drugmaker.
Investors Don't Want To Make Emeritus Home
Investors sold off the stock due to a lack of transparency with earnings.
Scrap Heap For Steel Dynamics
Industry consolidation persists with takeover of Recycle South.
Blockbuster, Icahn Open Up Circuit City
The troubled electronics maker is opening its books to suitors.
Investors Punish AIG
AIG tumbles after posting $7.8B in losses and making $9.1B in writedowns.
Mylan Expelling Injectables
The generic drug manufacturer lowered guidance on bad earnings and pledged to sell its specialty drugmaker.
Copyright 2007 Forbes.com LLC
Emini Futures Daytrading Course
Learn to Trade Stocks, ETFs, and Options